ASK REDCHAT ANYTHING ABOUT PROTARA THERAPEUTICS INC.
Protara Therapeutics Inc. (NASDAQ: TARA)
Listen to this Section
$4.35
+0.1250
(
+2.96% )
149.7K
Sign up for The Small Stocks Big Money Newsletter and receive free small-cap news and insights.
Clinical Trial Pipeline Stages
| Drug Name |
Stage |
| IV Choline chlorideDetailsLiver disease, Intestinal failure associated liver disease |
Phase 3 |
| TARA-002DetailsBladder cancer, Non-muscle invasive bladder cancer, Lymphatic malformations, Cancer, Solid tumor/s |
Phase 2 |
| TARA-002DetailsNon-muscle invasive bladder cancer, Bladder cancer |
Phase 1b |
| TARA-002DetailsLymphatic malformations, Bladder cancer, Non-muscle invasive bladder cancer, Cancer, Solid tumor/s |
Phase 2 |
| TARA-002DetailsBladder cancer, Non-muscle invasive bladder cancer |
Phase 2 |
Market Data
|
| Open |
$4.35 |
| Previous Close |
$4.22 |
| Volume |
149.7K |
| Market Cap |
$237.18M |
| Day Range |
$4.25 - $4.48 |
| 52 Week Range |
$2.77 - $7.82 |
| Shares Outstanding |
56.20M |
| Change % |
+2.96% |
| Net Change |
▲ 0.1250 |
| Insider Ownership |
-0.01% |
| Exchange |
NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) |
| IPO Year | 2020 |
| Country | United States |
Insider Ownership Transactions
Total Amount Purchased:
-394,479.00
| Date |
Type |
Amount Purchased |
Purchaser |
| 2025-05-16 |
Buy |
20000.00 |
Levy Richard S |
| 2024-07-18 |
Sale |
-7896.00 |
Opaleye Management Inc. |
| 2024-07-11 |
Sale |
-5997.00 |
Opaleye Management Inc. |
| 2024-07-03 |
Sale |
-5788.00 |
Opaleye Management Inc. |
| 2024-06-28 |
Sale |
-34103.00 |
Opaleye Management Inc. |
| 2024-06-27 |
Sale |
-6500.00 |
Opaleye Management Inc. |
| 2024-06-10 |
Sale |
-10000.00 |
Huang Jane |
| 2024-06-10 |
Sale |
-10000.00 |
SARGEN GREGORY |
| 2024-06-10 |
Sale |
-10000.00 |
GARCEAU ROGER |
| 2024-06-10 |
Sale |
-10000.00 |
Smith Cynthia |